Caribou Biosciences CRBU
NASDAQ CRBU
$0.56 +0.02 (+2.87%)
At close: Oct 22, 2026 · 4:00 PM EDT

Caribou Biosciences (CRBU) Interest Expenses (2020 - 2021)

Updated

Caribou Biosciences (CRBU) reported Interest Expenses of $8,000 for FY2021, down 60.0% from $20,000 in FY2020.

Analysis

Caribou Biosciences (CRBU) Interest Expenses (2020 - 2021) Analysis & Trends

  • According to Business Quant data, Interest Expenses came in at $20,000 in FY2020 (+400.0%) and $4,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 217.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 435.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 247.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Caribou Biosciences 56.06 Mn -460.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 2,000.00
Dec 31, 2020 6,000.00
Sep 30, 2020 6,000.00
Jun 30, 2020 5,000.00
API Access

Caribou Biosciences Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=CRBU&period=max&api_key=YOUR_API_KEY